Dual-action Doxyfylline 400mg & Acebrophylline 100mg tablets for comprehensive relief in asthma, COPD, and airway obstruction.
Doxobest-AB Tablets (Best Biotech) combine Doxyfylline (400 mg) and Acebrophylline (100 mg) to offer a powerful, synergistic approach to managing acute and chronic obstructive airway diseases. By pairing a novel bronchodilator with an advanced mucolytic and anti-inflammatory agent, Doxobest-AB effectively addresses both smooth muscle constriction and excessive mucus hypersecretion.
Unlike conventional methylxanthines, Doxyfylline provides potent bronchodilation with significantly reduced cardiac and gastrointestinal side effects. Acebrophylline complements this by thinning viscous pulmonary secretions, stimulating surfactant production, and suppressing local airway inflammation. Doxobest-AB improves lung function, reduces dyspnea, and decreases the frequency of exacerbations in patients suffering from asthma and COPD.
This dual-action respiratory tablet combines the bronchodilatory effects of Doxyfylline with the mucolytic and anti-inflammatory action of Acebrophylline, offering effective relief from airway obstruction and breathlessness.
Doxyfylline 400 mg: Relaxes smooth muscles of the airways, improves airflow, and eases breathing without excessive cardiac stimulation.
Acebrophylline 100 mg: Reduces mucus viscosity, eases cough, and decreases airway inflammation, improving overall respiratory function.
Dual-action bronchodilator & mucolytic therapy
Improves breathing and airway clearance
Reduces inflammation in respiratory passages
Convenient oral tablet dosage
Note: Use under medical supervision. Follow dosage as prescribed by a healthcare professional.
Standard Dosage: One tablet twice daily, or as strictly directed by a Pulmonologist or Physician.
Administration: Swallow whole with a glass of water after meals to ensure optimal tolerance. Do not crush or chew.
To be taken strictly under medical prescription and supervision.
